Geode Capital Management, LLC Opgen Inc Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.12 - $62.0 $98 - $50,654	-817 Reduced 0.23%	361,863 $51,000
Q2 2022 Aug 12, 2022	BUY	$0.32 - $0.79 $3,031 - $7,482	9,472 Added 2.68%	362,680 $197,000
Q3 2021 Nov 12, 2021	BUY	$2.18 - $3.58 $71,667 - $117,692	32,875 Added 10.26%	353,208 $1.02 Million
Q2 2021 Aug 13, 2021	BUY	$1.95 - $2.8 $244,352 - $350,865	125,309 Added 64.25%	320,333 $727,000
Q1 2021 May 12, 2021	BUY	$1.8 - $3.55 $211,802 - $417,721	117,668 Added 152.11%	195,024 $487,000
Q4 2020 Feb 12, 2021	BUY	$1.7 - $2.47 $21,743 - $31,591	12,790 Added 19.81%	77,356 $157,000
Q3 2020 Nov 13, 2020	BUY	$1.98 - $3.37 $16,633 - $28,311	8,401 Added 14.96%	64,566 $136,000
Q2 2020 Aug 13, 2020	BUY	$1.88 - $2.59 $105,590 - $145,467	56,165 New	56,165 $114,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $63.4M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.